FTY720 in patients with Uveitis

• Research type

  Research Study

• Full title

  A multicenter, randomized, active-controlled study to assess the safety, tolerability, and efficacy of FTY720 in patients with acute, noninfectious intermediate, posterior and pan uveitis

• IRAS ID

  117519

• Contact name

  Andrew Dick

• Contact email

  a.dick@bristol.ac.uk

• Sponsor organisation

  Novartis Pharma Service AG

• Eudract number

  2011-004160-30

• REC name

  South West - Central Bristol Research Ethics Committee

• REC reference

  13/SW/0072

• Date of REC Opinion

  8 May 2013

• REC opinion

  Further Information Favourable Opinion